Literature DB >> 27245772

CORR Insights(®): Are Females at Greater Risk for Revision Surgery After Hip Resurfacing Arthroplasty With the Articular Surface Replacement Prosthesis?

Alexander Jaime Grübl1.   

Abstract

Mesh：

Year:  2016        PMID： 27245772      PMCID： PMC5014813          DOI： 10.1007/s11999-016-4913-1

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  6 in total

1.  Independent predictors of revision following metal-on-metal hip resurfacing: a retrospective cohort study using National Joint Registry data.

Authors:  S S Jameson; P N Baker; J Mason; M L Porter; D J Deehan; M R Reed
Journal:  J Bone Joint Surg Br       Date:  2012-06

Review 2.  Do Complication Rates Differ by Gender After Metal-on-metal Hip Resurfacing Arthroplasty? A Systematic Review.

Authors:  Bryan D Haughom; Brandon J Erickson; Michael D Hellman; Joshua J Jacobs
Journal:  Clin Orthop Relat Res       Date:  2015-08       Impact factor: 4.176

3.  Long-term follow-up of metal-on-metal total hip replacement.

Authors:  Alexander Grübl; Martina Marker; Wolfram Brodner; Alexander Giurea; Georg Heinze; Vanee Meisinger; Harald Zehetgruber; Rainer Kotz
Journal:  J Orthop Res       Date:  2007-07       Impact factor: 3.494

4.  Failure rates of metal-on-metal hip resurfacings: analysis of data from the National Joint Registry for England and Wales.

Authors:  Alison J Smith; Paul Dieppe; Peter W Howard; Ashley W Blom
Journal:  Lancet       Date:  2012-10-02       Impact factor: 79.321

5.  Outcome of primary resurfacing hip replacement: evaluation of risk factors for early revision.

Authors:  Gareth H Prosser; Piers J Yates; David J Wood; Stephen E Graves; Richard N de Steiger; Lisa N Miller
Journal:  Acta Orthop       Date:  2010-02       Impact factor: 3.717

6.  The effect of a manufacturer recall on the threshold to revise a metal-on-metal hip.

Authors:  Saket Tibrewal; Shiraz Sabah; Johann Henckel; Alister Hart
Journal:  Int Orthop       Date:  2014-05-15       Impact factor: 3.075
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.